SARAH JIAN: Open Payments
NPI 1639571391 · DALLAS, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$484 in 9 payments from 7 companies in 2025. Trend: 2023 $494 · 2024 $114 · 2025 $484
Food & beverage: $484
| Company | Payments | Amount |
|---|---|---|
| Aimmune Therapeutics, Inc. | 2 | $236 |
| AstraZeneca Pharmaceuticals LP | 1 | $119 |
| Merck Sharp & Dohme LLC | 1 | $33 |
| ABBVIE INC. | 1 | $28 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $26 |
| Electromed, Inc. | 2 | $25 |
| Paratek Pharmaceuticals, Inc. | 1 | $17 |
Products named: ZENPEP, FASENRA, ZERBAXA, EMBLAVEO, SMARTVEST, NUZYRA.
Industry payments across TX — which companies pay providers there.
